CONCLUSION
By examining follow-up data in patients with suspected ACEi-AE, our
study revealed that misdiagnosis is frequent in this population.
Patients with a diagnosis of ACEi-AE confirmed by follow-up had attacks
that could display characteristics classically associated with
histamine-mediated AE and were responsive to icatibant. These results
need to be confirmed on prospective studies performed on larger cohorts.